NCT04161976View on ClinicalTrials.gov

A Study of LY900027 Given by Insulin Pump to Participants With Type 1 Diabetes Mellitus

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 27, 2019

Primary Completion Date

July 14, 2020

Study Completion Date

July 14, 2020

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

LY900027

LY900027 administered to participants with T1DM using CSII.

DRUG

Insulin Lispro

Insulin lispro administered to participants with T1DM using CSII.

Trial Locations (1)

41460

Profil Institut für Stoffwechselforschung, Neuss

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT04161976 - A Study of LY900027 Given by Insulin Pump to Participants With Type 1 Diabetes Mellitus | Biotech Hunter | Biotech Hunter